Welcome to the latest issue of our International Life Sciences Review, produced by our life sciences lawyers in the US, Europe and Asia and covering some of the most critical developments in the pharmaceutical and medical technology sectors in the last month. If you have questions on any of these topics, please contact please contact Paul Ranson.
In this issue, we cover updates relating to:
Read the eighth issue of the International Life Sciences Review >>